HIGHLIGHTS
- who: Olivia Wu and colleagues from the Health Economics and Health Technology Assessment, Institute of Health and Wellbeing, University of Glasgow, Glasgow , RZ, UK have published the Article: Effectiveness and Safety of Nonvitamin K Oral Anticoagulants Rivaroxaban and Apixaban in Patients with Venous Thromboembolism: A Meta-Analysis of Real-World Studies, in the Journal: Cardiovascular ue020erapeutics of 25/02/2022
- what: This analysis is aimed at assessing the real-world effectiveness of RIV and API, as the most frequently used NOACs, versus SoC by pooling the results from the published real-world studies using meta . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.